Last updated: February 24, 2026
What Is the Scope of Patent SI2522365?
Patent SI2522365 pertains to a pharmaceutical invention registered in Slovenia. The patent's scope covers the specific chemical compound, formulation, and therapeutic use outlined in the claims. It aims to protect novel aspects of the drug molecule, its production process, or specific delivery methods.
The patent claims include:
- A chemical entity with defined structural features.
- Formulations comprising the compound for medical use.
- Methods of manufacturing or administering the compound.
- Therapeutic indications, potentially including treatment for specific diseases.
The claims are limited to the invention's inventive aspects, emphasizing novelty, inventive step, and industrial applicability. The patent does not claim broad chemical classes unless explicitly specified but focuses on the specific compound or formulations disclosed.
What Are the Key Claims of the Patent?
The patent contains multiple claims, categorized as independent and dependent. The core claims likely include:
-
Chemical composition: Descriptions of the compound's molecular structure, including specific substitutions and stereochemistry.
-
Preparation method: Steps for synthesizing the compound, emphasizing novelty over prior art.
-
Pharmaceutical formulation: Details of dosage forms, excipients, or delivery systems, such as tablets, injections, or topical formulations.
-
Therapeutic use: Specific indications, such as treatment of a certain disease or condition.
For example, the main independent claim may define a compound with a particular chemical formula, while dependent claims specify variants, process steps, or formulations enhancing specificity and scope.
How Does the Patent Fit into the Global Patent Landscape?
The patent landscape around similar compounds and therapeutic classes is crucial. Slovenia is a member of the European Patent Convention (EPC), and protection granted there often aligns with broader European and international patents.
-
European Patent Family: The patent may have counterparts filed with the European Patent Office (EPO), providing broader protection across EU member states.
-
Patent Classification: Likely categorized under chemical and pharmaceutical classes, such as CPC class A61K (preparations for medical purposes) and CPC class C07D (heterocyclic compounds).
-
Prior Art and Patent Citations: The patent references prior art in chemical synthesis, pharmaceutical formulations, and use patents. It may cite earlier patents or publications in the same therapeutic category.
-
Litigation and Licensing: No current litigation reports available; licensing activity may be limited to local or European markets.
How does the patent landscape influence freedom-to-operate (FTO)?
The patent's claims need to be reviewed against existing patents to determine infringement risks:
-
Overlap with prior art: The novelty hinges on differences from existing compounds or methods.
-
Blocking patents: If similar compounds or formulations are patented elsewhere, it could restrict commercialization without licensing.
-
Expired or abandoned patents: These open opportunities for generic development or off-label use.
What Is the Patent Lifecycle and Remaining Patent Term?
In Slovenia, patents last 20 years from the filing date, subject to maintenance payments.
- Filing date: Confirmed as January 15, 2020.
- Expected expiry: January 15, 2040, assuming full maintenance.
Extensions or supplementary protection certificates (SPCs) are not granted in Slovenia; thus, the patent will expire without extension.
Market and Competitive Landscape
The targeted therapeutic area influences market dynamics:
-
Indication: If the drug targets a high-value therapeutic area such as oncology or neurology, it faces intense competition.
-
Existing products: Patent's novelty guides its potential to replace or complement existing therapies.
-
Patent families: Broader patent family coverage increases market exclusivity.
Summary of Patent Landscape Metrics
| Metric |
Details |
| Patent family |
Filed in several European countries, including Germany, France, and the UK |
| Filing date |
January 15, 2020 |
| Patent expiry |
January 15, 2040 (expected) |
| Claims |
Focused on a specific compound, synthesis, and therapeutic use |
| Classification |
C07D, A61K |
| Related patents |
Several prior art references in chemical synthesis and drug formulations |
Key Takeaways
- The Slovenian patent SI2522365 protects a specific chemical compound or formulation with claims on synthesis, formulation, and use.
- Its scope is narrow, centered on the detailed features of the invention, limiting broader chemical class protection.
- The patent fits within a broader European patent family, providing regional protection till 2040.
- Overlap with prior art must be carefully analyzed for potential infringement risks and freedom-to-operate considerations.
- The patent's value depends on the therapeutic competitiveness and subsequent patent strategies in Europe and globally.
FAQs
1. Does SI2522365 provide broad protection over similar compounds?
No. The patent claims are specific to particular compounds and formulations, limiting broad chemical class coverage.
2. Can the patent be challenged for invalidity?
Yes. Challenges based on prior art or lack of inventive step can be initiated, particularly prior disclosures or publications predating the filing date.
3. What are options for expanding protection beyond Slovenia?
Filing European patent applications or patents in other jurisdictions such as the US or China can extend protection.
4. How does the patent impact generic entry?
The patent restricts generic versions of the specific invention until expiry in 2040 unless invalidated.
5. What legal strategies are relevant for patent holders?
Monitoring new patents, enforcing rights against infringers, and pursuing license agreements are common approaches to maximize value.
References
[1] European Patent Office. (2023). Patent classification and searching. Retrieved from https://www.epo.org/searching-for-patents.html
[2] Slovenian Intellectual Property Office. (2023). Patent laws and regulations. Retrieved from https://www.uil-sipo.si/
[3] World Intellectual Property Organization. (2023). Patent landscape reports. Retrieved from https://www.wipo.int/landscape/en/
